INDIANAPOLIS (May 18, 2021)—Apria, Inc. announced that it has appointed Susannah Gray and Terri Kline to the company’s board of directors. Both will serve on the board’s Audit Committee.
Gray possesses a wealth of experience in health care leadership, serving in board of director and committee capacities at 4D Molecular Therapeutics, Maravai Life Sciences, Morphic Therapeutics, BioSplice Therapeutics, Wesleyan University, the Susan G. Komen Foundation, Street Squash and the German Marshall Fund. She also served as executive vice president and chief financial officer of Royalty Pharma, the largest aggregator of pharmaceutical royalty interests worldwide, and held roles at Chase Securities, Merrill Lynch and CIBC World Markets. Gray holds a Master of Business Administration from Columbia University and a Bachelor of Arts from Wesleyan University.
Kline brings to Apria deep expertise in health care advisory and currently serves on the boards of Amedisys, Intersect ENT, SaVida Health and Presbyterian Health Plan, Inc. Previously, she served as executive vice president of Henry Ford Health System (HFHS), as president and chief executive officer of Health Alliance Plan—a subsidiary of HFHS—and as senior vice president and chief health care management officer of Health Care Service Corporation. Kline holds a Master of Public Health from the University of Michigan and a Bachelor of Arts from Kalamazoo College.
“With decades of combined experience in healthcare leadership and advisory, Susannah Gray and Terri Kline significantly strengthen the expertise of our Company’s Board of Directors,” said Dan Starck, CEO of Apria. “Our executive leadership and board are pleased to add two individuals with their stellar reputations, and both will undoubtedly help guide us through our next phase of growth, as we continue to strive to improve the quality of life for our patients at home.”
Visit apria.com for more information.
